A. Bergantin

About

Dr. A. Bergantin is a pioneering figure in image-guided robotic radiosurgery, with a career focused on expanding the therapeutic reach of the CyberKnife platform. Their research centers on three key areas: treating recurrent prostate cancer, managing medically resistant trigeminal neuralgia (TN), and navigating complex oncological cases. Dr. Bergantin’s major contributions include demonstrating the feasibility and safety of CyberKnife as salvage therapy for locally recurrent prostate cancer after external beam irradiation, a landmark study that has garnered 49 citations. In the field of TN, they have led the largest single-center experience to date, reporting on over 560 cases and establishing a three-year follow-up protocol for 387 treatments, with their 2017 and 2019 papers accumulating 38 and 35 citations respectively. Their work has redefined non-isocentric, frameless irradiation of the trigeminal nerve, offering new hope for patients with refractory pain. Notably, Dr. Bergantin also reported a highly innovative case of staged radiosurgery for a malignant glioma during pregnancy, successfully treating the mother while preserving the fetus. With a cumulative impact of over 126 citations across these seminal works, Dr. Bergantin stands as a leader in advancing minimally invasive, image-guided solutions for some of the most challenging conditions in radiation oncology.

Research Focus

Key Achievements

Top Papers

1. 1
   Image-Guided Robotic Radiosurgery as Salvage Therapy for Locally Recurrent Prostate Cancer after External Beam Irradiation: Retrospective Feasibility Study on Six Cases

   49 citations · 2010
2. 2
   Image-Guided Robotic Radiosurgery for Trigeminal Neuralgia

   38 citations · 2017
3. 3
   Cyberknife Radiosurgery for Trigeminal Neuralgia

   35 citations · 2019
4. 4
   Staged Image-guided Robotic Radiosurgery and Deferred Chemotherapy to Treat a Malignant Glioma During and After Pregnancy

   4 citations · 2018

Key Collaborators

Contact & Links